These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 24059802)
21. Methods for genome-wide analysis of DNA methylation in intestinal tumors. Hahn MA; Pfeifer GP Mutat Res; 2010 Nov; 693(1-2):77-83. PubMed ID: 19854208 [TBL] [Abstract][Full Text] [Related]
22. Genomic and epigenomic integration identifies a prognostic signature in colon cancer. Yi JM; Dhir M; Van Neste L; Downing SR; Jeschke J; Glöckner SC; de Freitas Calmon M; Hooker CM; Funes JM; Boshoff C; Smits KM; van Engeland M; Weijenberg MP; Iacobuzio-Donahue CA; Herman JG; Schuebel KE; Baylin SB; Ahuja N Clin Cancer Res; 2011 Mar; 17(6):1535-45. PubMed ID: 21278247 [TBL] [Abstract][Full Text] [Related]
23. Identifying CpG sites with different differential methylation frequencies in colorectal cancer tissues based on individualized differential methylation analysis. Yan H; He J; Guan Q; Cai H; Zhang L; Zheng W; Qi L; Zhang S; Liu H; Li H; Zhao W; Yang S; Guo Z Oncotarget; 2017 Jul; 8(29):47356-47364. PubMed ID: 28537885 [TBL] [Abstract][Full Text] [Related]
24. Methylation associated transcriptional repression of ELOVL5 in novel colorectal cancer cell lines. Boot A; Oosting J; van Eendenburg JDH; Kuppen PJK; Morreau H; van Wezel T PLoS One; 2017; 12(9):e0184900. PubMed ID: 28931069 [TBL] [Abstract][Full Text] [Related]
25. Identification of diagnostic markers in colorectal cancer via integrative epigenomics and genomics data. Kok-Sin T; Mokhtar NM; Ali Hassan NZ; Sagap I; Mohamed Rose I; Harun R; Jamal R Oncol Rep; 2015 Jul; 34(1):22-32. PubMed ID: 25997610 [TBL] [Abstract][Full Text] [Related]
26. Epigenetic Biomarkers in Colorectal Cancer. Verma M; Kumar V Mol Diagn Ther; 2017 Apr; 21(2):153-165. PubMed ID: 27878475 [TBL] [Abstract][Full Text] [Related]
27. Genome-wide identification and validation of a novel methylation biomarker, SDC2, for blood-based detection of colorectal cancer. Oh T; Kim N; Moon Y; Kim MS; Hoehn BD; Park CH; Kim TS; Kim NK; Chung HC; An S J Mol Diagn; 2013 Jul; 15(4):498-507. PubMed ID: 23747112 [TBL] [Abstract][Full Text] [Related]
28. Circulating cell-free nucleic acids as biomarkers in colorectal cancer screening and diagnosis. Tóth K; Barták BK; Tulassay Z; Molnár B Expert Rev Mol Diagn; 2016; 16(2):239-52. PubMed ID: 26652067 [TBL] [Abstract][Full Text] [Related]
29. Intermediate- and low-methylation epigenotypes do not correspond to CpG island methylator phenotype (low and -zero) in colorectal cancer. Karpinski P; Walter M; Szmida E; Ramsey D; Misiak B; Kozlowska J; Bebenek M; Grzebieniak Z; Blin N; Laczmanski L; Sasiadek MM Cancer Epidemiol Biomarkers Prev; 2013 Feb; 22(2):201-8. PubMed ID: 23175427 [TBL] [Abstract][Full Text] [Related]
30. Genetic and epigenetic aberrations occurring in colorectal tumors associated with serrated pathway. Sakai E; Fukuyo M; Ohata K; Matsusaka K; Doi N; Mano Y; Takane K; Abe H; Yagi K; Matsuhashi N; Fukushima J; Fukayama M; Akagi K; Aburatani H; Nakajima A; Kaneda A Int J Cancer; 2016 Apr; 138(7):1634-44. PubMed ID: 26510091 [TBL] [Abstract][Full Text] [Related]
31. Stool DNA methylation assays in colorectal cancer screening. Kadiyska T; Nossikoff A World J Gastroenterol; 2015 Sep; 21(35):10057-61. PubMed ID: 26401070 [TBL] [Abstract][Full Text] [Related]
32. DNA methylation biomarkers in colorectal cancer: Clinical applications for precision medicine. Fatemi N; Tierling S; Es HA; Varkiani M; Mojarad EN; Aghdaei HA; Walter J; Totonchi M Int J Cancer; 2022 Dec; 151(12):2068-2081. PubMed ID: 35730647 [TBL] [Abstract][Full Text] [Related]
33. MethyLight droplet digital PCR for detection and absolute quantification of infrequently methylated alleles. Yu M; Carter KT; Makar KW; Vickers K; Ulrich CM; Schoen RE; Brenner D; Markowitz SD; Grady WM Epigenetics; 2015; 10(9):803-9. PubMed ID: 26186366 [TBL] [Abstract][Full Text] [Related]
34. DNA methylation biomarkers and their utility for solid cancer diagnostics. Heichman KA; Warren JD Clin Chem Lab Med; 2012 Oct; 50(10):1707-21. PubMed ID: 23089699 [TBL] [Abstract][Full Text] [Related]
35. The role of epigenetic therapies in colorectal cancer. Baretti M; Azad NS Curr Probl Cancer; 2018 Nov; 42(6):530-547. PubMed ID: 29625794 [TBL] [Abstract][Full Text] [Related]
36. Methylation of TMEM176A is an independent prognostic marker and is involved in human colorectal cancer development. Gao D; Han Y; Yang Y; Herman JG; Linghu E; Zhan Q; Fuks F; Lu ZJ; Guo M Epigenetics; 2017 Jul; 12(7):575-583. PubMed ID: 28678648 [TBL] [Abstract][Full Text] [Related]
37. Aberrant DNA Methylation in Colorectal Cancer: What Should We Target? Tse JWT; Jenkins LJ; Chionh F; Mariadason JM Trends Cancer; 2017 Oct; 3(10):698-712. PubMed ID: 28958388 [TBL] [Abstract][Full Text] [Related]
38. Prognostic value of MGMT methylation in colorectal cancer: a meta-analysis and literature review. Li Y; Lyu Z; Zhao L; Cheng H; Zhu D; Gao Y; Shang X; Shi H Tumour Biol; 2015 Mar; 36(3):1595-601. PubMed ID: 25596081 [TBL] [Abstract][Full Text] [Related]
39. EYA4 Acts as a New Tumor Suppressor Gene in Colorectal Cancer. Kim SJ; Tae CH; Hong SN; Min BH; Chang DK; Rhee PL; Kim JJ; Kim HC; Kim DH; Kim YH Mol Carcinog; 2015 Dec; 54(12):1748-57. PubMed ID: 25620232 [TBL] [Abstract][Full Text] [Related]
40. Molecular biomarkers for an early diagnosis, effective treatment and prognosis of colorectal cancer: Current updates. Mahasneh A; Al-Shaheri F; Jamal E Exp Mol Pathol; 2017 Jun; 102(3):475-483. PubMed ID: 28506769 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]